NCT04892017 · Interventional trial
Study of Inlexisertib (DCC-3116) in Participants With RAS/MAPK Pathway Mutant Solid Tumors
Overall registry status Terminated
Phase 1
Conditions Advanced Solid Tumor, Metastatic Solid Tumor, Non-Small Cell Lung Cancer
Delaware Valley sites
- Hospital of the University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory